Supplementary Tables S1-S16 from Mutagenic Impact and Evolutionary Influence of Chemoradiotherapy in Hematologic Malignancies

Table S1: Demographic Data. Table S2: Exposure History LBCL. Table S3: Exposure History Myeloma. Tables S4: Exposure History for t-MN from PMID: 36626250. Table S5: ID83 Mutational Signatures Contribution for the Patient-Level Lymphoid Cohort. Table S6: Mutational Signatures Contribution for the Patient-Level Lymphoid Cohort. Table S6: Mutational Signatures Contribution for the Patient-Level Lymphoid Cohort. Table S8: ID8 is independent of genomic complexity in MM. p-values reflect wilcoxcon test of ID8 positive cases stratified by genomic. Table S9: Characteristics of single-cell-derived colonies. Table S10: Viability of DHL-4 cells post treatment (in 10^3 cells). Table S11: De novo mutional signatures extraction for single-cell-derived colonies. Table S12: De novo signature contributions for each colony. Table S13: Signal to Noise Ratios for ChemoRT-Exposed Single Cell-Derived Colonies. Table S14: De-noised mutational and indel signatures fitting of single-cell-derived colonies. Table S15: ID signature fitting to indel profiles of an induced pluripotent stem cell line (Kucab and colleagues, 2019) exposed to various mutagenic and non-mutagenic chemotherapies. Table S16: Indel Signature Re-fit for t-MN samples